CANF - Can Fite Biopharma Ltd Sponsored ADR Stock Trading

Can-Fite Biopharma Ltd Sponsored ADR(NYSE: CANF) stock trading, description, contact, officers and directors.

About Can-Fite Biopharma Ltd Sponsored ADR

None

Stock Information

Can-Fite Biopharma Ltd Sponsored ADR Company Name:

CANF Stock Symbol:

NYSE Market:

Get CANF Alerts

News, Short Squeeze, Breakout and More Instantly...

CANF - Can-Fite Gears Up to Initiate Pivotal Phase III Liver Cancer Study

FDA Granted Namodenoson Orphan Drug and Fast Track Status Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announc...
CANF - Can-Fite Enters Projected $3 Billion Veterinary Osteoarthritis Market: Signs Agreement with Vetbiolix for Development of Piclidenoson for Pets

All pre-clinical, clinical, and regulatory development work to be conducted and financially covered by Vetbiolix Veterinary market has potential for a shorter path to regulatory approval and product revenues Can-Fite BioPharma Ltd . (NYSE American: CA...
CANF - Can-Fite Receives Notice of Patent Allowance in China for NASH Treatment

Namodenoson is out-licensed in China for NASH, projected to become $6.4 billion market by 2027 Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, canc...